Guidelines and Audit Measures for the Specialist Supervision of Patients with Rheumatoid Arthritis. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians

Overview

Journal J R Coll Physicians Lond

Specialty General Medicine

Date 1992 Jan 1

PMID 1573591

Citations 9

Affiliations

Soon will be listed here.

Citing Articles

Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status-results from the early rheumatoid arthritis study.

Zhao S, Nikiphorou E, Young A, Kiely P Rheumatol Int. 2021; 42(4):621-629.

PMID: 34398259 PMC: 8940793. DOI: 10.1007/s00296-021-04931-2.

A systematic review of guidelines for managing rheumatoid arthritis.

Mian A, Ibrahim F, Scott D BMC Rheumatol. 2019; 3:42.

PMID: 31660534 PMC: 6805606. DOI: 10.1186/s41927-019-0090-7.

Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network.

Nikiphorou E, Norton S, Carpenter L, Walsh D, Creamer P, Dixey J Rheumatology (Oxford). 2019; 59(6):1272-1280.

PMID: 31580448 PMC: 7244786. DOI: 10.1093/rheumatology/kez461.

Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.

Kiely P, Busby A, Nikiphorou E, Sullivan K, Walsh D, Creamer P BMJ Open. 2019; 9(5):e028466.

PMID: 31061059 PMC: 6501950. DOI: 10.1136/bmjopen-2018-028466.

Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis.

Mattey D, Nixon N, Dawes P Arthritis Res Ther. 2012; 14(5):R204.

PMID: 23031278 PMC: 3580516. DOI: 10.1186/ar4042.

References

Lawrence J . Prevalence of rheumatoid arthritis. Ann Rheum Dis. 1961; 20:11-7. PMC: 1007178. DOI: 10.1136/ard.20.1.11. View

. GOLD therapy in rheumatoid arthritis. Report of a multicentre control trial. Ann Rheum Dis. 1960; 19:95-119. PMC: 1007132. View

Singh G, Fries J, Williams C, Zatarain E, Spitz P, Bloch D . Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 1991; 18(2):188-94. View

STEINBROCKER O, TRAEGER C, BATTERMAN R . Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949; 140(8):659-62. DOI: 10.1001/jama.1949.02900430001001. View

Capell H, Marabani M, Madhok R, Torley H, Hunter J . Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period. Q J Med. 1990; 75(276):335-44. View

Felson D, Anderson J, Meenan R . The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum. 1990; 33(10):1449-61. DOI: 10.1002/art.1780331001. View

Wong C, Champion G, Smith M, Soden M, Wetherall M, Geddes R . Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study. Ann Rheum Dis. 1990; 49(6):370-2. PMC: 1004102. DOI: 10.1136/ard.49.6.370. View

Gabriel S, Bombardier C . NSAID induced ulcers. An emerging epidemic?. J Rheumatol. 1990; 17(1):1-4. View

Weinblatt M, Kaplan H, Germain B, Merriman R, Solomon S, Wall B . Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial. Arthritis Rheum. 1990; 33(3):330-8. DOI: 10.1002/art.1780330305. View

10.

McCune W, Bayliss G . Immunosuppressive drug therapy. Curr Opin Rheumatol. 1990; 2(3):497-505. DOI: 10.1097/00002281-199002030-00014. View

11.

Spector T . Rheumatoid arthritis. Rheum Dis Clin North Am. 1990; 16(3):513-37. View

12.

MCDUFFIE F . How we got to be where we are. J Rheumatol Suppl. 1990; 25:1-3. View

13.

Reilly P, Cosh J, Maddison P, Rasker J, Silman A . Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis. 1990; 49(6):363-9. PMC: 1004101. DOI: 10.1136/ard.49.6.363. View

14.

van der Heijde D, van Riel P, Nuver-Zwart I, Gribnau F, vad de Putte L . Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989; 1(8646):1036-8. DOI: 10.1016/s0140-6736(89)92442-2. View

15.

Hess E, Luggen M . Remodeling the pyramid--a concept whose time has not yet come. J Rheumatol. 1989; 16(9):1175-6. View

16.

Scott D, Spector T, Pullar T, MCCONKEY B . What should we hope to achieve when treating rheumatoid arthritis?. Ann Rheum Dis. 1989; 48(3):256-61. PMC: 1003733. DOI: 10.1136/ard.48.3.256. View

17.

WILSKE K, Healey L . Remodeling the pyramid--a concept whose time has come. J Rheumatol. 1989; 16(5):565-7. View

18.

Pullar T, Capell H . Selection of suitable patients for second-line therapy in rheumatoid arthritis. Br J Rheumatol. 1986; 25(3):276-81. DOI: 10.1093/rheumatology/25.3.276. View

19.

Scott D, Symmons D, Coulton B, POPERT A . Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet. 1987; 1(8542):1108-11. DOI: 10.1016/s0140-6736(87)91672-2. View

20.

Graham D, Agrawal N, Roth S . Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988; 2(8623):1277-80. DOI: 10.1016/s0140-6736(88)92892-9. View